Arthur Andrew Medical – Trademark Portfolio

Entity Type: 03

Arthur Andrew Medical holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 13 trademarks are registered. Notable registered marks include FEMESSE, KD ULTRA, NOVEQUIN, PROFERIA, and AMINOLASE. The owner is based in Scottsdale, AZ.

8350 E. Raintree Dr.

#101

Scottsdale, AZ 85260

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Arthur Andrew Medical's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Arthur Andrew Medical have?

Arthur Andrew Medical has 15 U.S. trademarks filed with the USPTO. Of these, 13 registered, 2 cancelled.

What trademark classes does Arthur Andrew Medical file in?

Arthur Andrew Medical files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Arthur Andrew Medical's most well-known trademarks?

Arthur Andrew Medical's registered trademark portfolio includes well-known marks such as FEMESSE, KD ULTRA, NOVEQUIN, PROFERIA, and AMINOLASE. These are among 13 currently registered trademarks in the portfolio.

What is Arthur Andrew Medical's trademark registration success rate?

Arthur Andrew Medical has a 87% trademark registration rate, with 13 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.